K. Müller-vahl and H. Emrich, Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia, Expert Review of Neurotherapeutics, vol.192, issue.7, pp.1037-1048, 2008.
DOI : 10.1192/bjp.bp.107.046649

J. Allen, Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse, Gut, vol.53, issue.11, pp.1566-1570, 2004.
DOI : 10.1136/gut.2003.036350
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774264

M. Martinasek, J. Mcgrogan, and A. Maysonet, A Systematic Review of the Respiratory Effects of Inhalational Marijuana, Respiratory Care, vol.61, issue.11, pp.1543-1551, 2016.
DOI : 10.4187/respcare.04846

L. Strat, Y. , L. Foll, and B. , Obesity and Cannabis Use: Results From 2 Representative National Surveys, American Journal of Epidemiology, vol.174, issue.8, pp.929-933, 2011.
DOI : 10.1093/aje/kwr200

T. Rajavashisth, M. Shaheen, K. Norris, D. Pan, S. Sinha et al., Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III, BMJ Open, vol.2, issue.1, pp.494-22368296, 2012.
DOI : 10.1136/bmjopen-2011-000494

S. Sidney, Marijuana Use and Type 2 Diabetes Mellitus: a Review, Current Diabetes Reports, vol.298, issue.22, 2016.
DOI : 10.1001/jama.298.22.2654

S. Dagogo-jack, Diabetes risks from prescription and non-prescription drugs: mechanisms and approaches to risk reduction, 2016.

G. Vernon, A. Baranova, and Z. Younossi, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Alimentary Pharmacology & Therapeutics, vol.11, issue.6 Pt 2, pp.274-285, 2011.
DOI : 10.1016/j.cld.2007.02.002

R. Loomba and A. Sanyal, The global NAFLD epidemic, Nature Reviews Gastroenterology & Hepatology, vol.363, issue.11, pp.686-690, 2013.
DOI : 10.1055/s-0028-1091978

S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni, Epidemiology of Non-Alcoholic Fatty Liver Disease, Digestive Diseases, vol.28, issue.1, pp.155-161, 2010.
DOI : 10.1159/000282080

M. Ganz, T. Bukong, T. Csak, B. Saha, J. Park et al., Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat???cholesterol???sugar diet model in mice, Journal of Translational Medicine, vol.193, issue.1342???1359, p.26077675, 0193.
DOI : 10.1016/j.cbi.2011.07.001

M. Charlton, Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?, Hepatology, vol.129, issue.11 Suppl, pp.1431-1433, 2008.
DOI : 10.1053/j.gastro.2005.04.014

S. Bellentani, The epidemiology of non-alcoholic fatty liver disease, Liver International, vol.34, pp.81-84, 2017.
DOI : 10.2337/dc10-2229

R. Houchen, D. Ross, A. Elixhauser, and J. Jiang, Nationwide Inpatient Sample (NIS) Redesign Final Report, Healthcare Research and Quality, vol.https, 2014.

M. Olsen, Y. Young-xu, D. Stwalley, C. Kelly, D. Gerding et al., The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases, BMC Infectious Diseases, vol.61, issue.1, 2016.
DOI : 10.1093/ofid/ofu048

E. Penner, H. Buettner, and M. Mittleman, The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults, The American Journal of Medicine, vol.126, issue.7, pp.583-589, 2013.
DOI : 10.1016/j.amjmed.2013.03.002

J. Mcpartland and E. Russo, Cannabis and Cannabis Extracts, Journal of Cannabis Therapeutics, vol.56, issue.3-4, pp.103-132, 2001.
DOI : 10.1007/BF00432554

C. Andre, J. Hausman, and G. Guerriero, Cannabis sativa: The Plant of the Thousand and One Molecules, Frontiers in Plant Science, vol.37, issue.465, 2016.
DOI : 10.1007/s10529-015-1853-x

S. Burstein and . Cannabidiol, Cannabidiol (CBD) and its analogs: a review of their effects on inflammation, Bioorganic & Medicinal Chemistry, vol.23, issue.7, pp.1377-1385, 2015.
DOI : 10.1016/j.bmc.2015.01.059

D. Piomelli and E. Russo, Debate: An Interview with Ethan Russo, MD, Cannabis and Cannabinoid Research, vol.1, issue.1, pp.44-46, 2016.
DOI : 10.1089/can.2015.29003.ebr

D. Osei-hyiaman, M. Depetrillo, P. Pacher, J. Liu, S. Radaeva et al., Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, Journal of Clinical Investigation, vol.115, issue.5, pp.1298-1305, 2005.
DOI : 10.1172/JCI200523057
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161

F. Teixeira-clerc, B. Julien, P. Grenard, V. Nhieu, J. Deveaux et al., CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis, Nature Medicine, vol.30, issue.6, pp.671-676, 2006.
DOI : 10.1038/nm1421

F. Rossi, G. Bellini, L. Luongo, I. Manzo, S. Tolone et al., Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.9, pp.3469-3478, 2016.
DOI : 10.1210/jc.2015-4381

S. Batkai, D. Osei-hyiaman, H. Pan, O. El-assal, M. Rajesh et al., Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury, The FASEB Journal, vol.21, issue.8, pp.1788-1800, 2007.
DOI : 10.1096/fj.06-7451com
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252

E. Patsenker and F. Stickel, Cannabinoids in liver diseases, Clinical Liver Disease, vol.355, issue.2, pp.21-25, 2016.
DOI : 10.1124/jpet.115.226100

B. Julien, P. Grenard, F. Teixeira-clerc, V. Nhieu, J. Li et al., Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, vol.128, issue.3, pp.742-755, 2005.
DOI : 10.1053/j.gastro.2004.12.050

C. Giroud, Analysis of Cannabinoids in Hemp Plants, CHIMIA International Journal for Chemistry, vol.56, issue.3, pp.80-83, 2002.
DOI : 10.2533/000942902777680702

D. Brown, Cannabis: the genus Cannabis, 1998.
DOI : 10.4324/9780203304228

S. Kojima, N. Watanabe, M. Numata, T. Ogawa, and S. Matsuzaki, Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background, Journal of Gastroenterology, vol.38, issue.10, pp.954-961, 2003.
DOI : 10.1007/s00535-003-1178-8

Y. Eguchi, H. Hyogo, M. Ono, T. Mizuta, N. Ono et al., Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study, Journal of Gastroenterology, vol.46, issue.5, pp.586-595, 2012.
DOI : 10.1007/s00535-010-0340-3

L. Shen, J. Fan, Y. Shao, M. Zeng, J. Wang et al., Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey, World Journal of Gastroenterology, vol.9, issue.5, pp.1106-1110, 2003.
DOI : 10.3748/wjg.v9.i5.1106

T. Foster, F. Anania, D. Li, R. Katz, and M. Budoff, The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA), Digestive Diseases and Sciences, vol.51, issue.8, pp.2392-2398, 2013.
DOI : 10.1002/hep.23593

A. Lonardo, S. Lombardini, F. Scaglioni, S. Ballestri, A. Verrone et al., Fatty liver, carotid disease and gallstones: A study of age-related associations, World Journal of Gastroenterology, vol.12, issue.36, pp.5826-5833, 2006.
DOI : 10.3748/wjg.v12.i36.5826

C. Chen, M. Huang, J. Yang, C. Nien, C. Yang et al., Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults, Journal of Clinical Gastroenterology, vol.40, issue.8, pp.745-752, 2006.
DOI : 10.1097/00004836-200609000-00016

Z. Younossi, M. Stepanova, F. Negro, S. Hallaji, Y. Younossi et al., Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States, Medicine, vol.91, issue.6, pp.319-327, 2012.
DOI : 10.1097/MD.0b013e3182779d49

H. Nomura, S. Kashiwagi, J. Hayashi, W. Kajiyama, S. Tani et al., Prevalence of fatty liver in a general population of Okinawa, Japan., Japanese Journal of Medicine, vol.27, issue.2, pp.142-149, 1988.
DOI : 10.2169/internalmedicine1962.27.142

M. Bertolotti, A. Lonardo, C. Mussi, E. Baldelli, E. Pellegrini et al., Nonalcoholic fatty liver disease and aging: Epidemiology to management, World Journal of Gastroenterology, vol.20, issue.39, pp.14185-14204, 2014.
DOI : 10.3748/wjg.v20.i39.14185

G. Hunter, B. Gower, and B. Kane, Age Related Shift in Visceral Fat, Int J Body Compos Res, vol.8, pp.103-108, 2010.

Y. Eguchi, T. Eguchi, T. Mizuta, Y. Ide, T. Yasutake et al., Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease, Journal of Gastroenterology, vol.17, issue.5, pp.462-469, 2006.
DOI : 10.1148/radiology.211.1.r99ap15283

H. Azzam and S. Malnick, Non-alcoholic fatty liver disease - the heart of the matter, World Journal of Hepatology, vol.7, issue.10, pp.1369-1376, 2015.
DOI : 10.4254/wjh.v7.i10.1369

A. Lonardo, S. Sookoian, M. Chonchol, P. Loria, and G. Targher, Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD, Current Pharmaceutical Design, vol.19, issue.29, pp.5177-5192, 2013.
DOI : 10.2174/1381612811319290003

A. Hruby and F. Hu, The Epidemiology of Obesity: A Big Picture, PharmacoEconomics, vol.320, issue.7244, pp.673-689, 2015.
DOI : 10.1136/bmj.320.7244.1240

J. Levine, Poverty and Obesity in the U.S., Diabetes, vol.60, issue.11, pp.2667-2668, 2011.
DOI : 10.2337/db11-1118

Y. Bird, M. Lemstra, M. Rogers, and J. Moraros, The relationship between socioeconomic status/income and prevalence of diabetes and associated conditions: A cross-sectional population-based study in Saskatchewan, Canada, International Journal for Equity in Health, vol.182, issue.1, pp.93-26458543, 2015.
DOI : 10.1016/j.healthpol.2010.07.018

K. Katz, P. Brar, N. Parekh, Y. Liu, and M. Weitzman, Suspected Nonalcoholic Fatty Liver Disease Is Not Associated with Vitamin D Status in Adolescents after Adjustment for Obesity, Journal of Obesity, vol.3, issue.3, 2010.
DOI : 10.2337/db08-0593

S. Keating, D. Hackett, H. Parker, O. Connor, H. Gerofi et al., Effect of aerobic exercise training dose on liver fat and visceral adiposity, Journal of Hepatology, vol.63, issue.1, pp.174-182, 2015.
DOI : 10.1016/j.jhep.2015.02.022